Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias (Long QT Syndrome, Brugada Syndrome, CPVT and Early Repolarization Syndrome)

NCT02413450 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT02413450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02413450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias (Long QT Syndrome, Brugada Syndrome, CPVT and Early Repolarization Syndrome)
Lead sponsor
Johns Hopkins University
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 31, 2013
Completion date
August 31, 2031
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmogenic cardiomyopathy (ac, arvd/c), brugada syndrome (brs), catecholaminergic polymorphic ventricular tachycardia (cpvt), dilated cardiomyopathy (dcm), early repolarization syndrome (ers), hypertrophic cardiomyopathy (hcm), inherited cardiac arrythmias, long qt syndrome (lqts), muscular dystrophies (duchenne, becker, myotonic dystrophy), normal control subjects